APA (7th ed.) Citation

Ferrante, M., Irving, P. M., Abreu, M. T., Axler, J., Gao, X., Cao, Q., . . . Panaccione, R. (2024). Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial. Journal of Crohn's & Colitis, 18(3), 416. https://doi.org/10.1093/ecco-jcc/jjad168

Chicago Style (17th ed.) Citation

Ferrante, Marc, et al. "Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial." Journal of Crohn's & Colitis 18, no. 3 (2024): 416. https://doi.org/10.1093/ecco-jcc/jjad168.

MLA (9th ed.) Citation

Ferrante, Marc, et al. "Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial." Journal of Crohn's & Colitis, vol. 18, no. 3, 2024, p. 416, https://doi.org/10.1093/ecco-jcc/jjad168.